X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/21/2799815/0/en/invIOs-to-attend-JP-Morgan-Week-in-San-Francisco-in-January.html
https://www.globenewswire.com//news-release/2023/09/05/2736966/0/en/invIOs-starts-further-clinical-trial-of-APN401-novel-cell-therapy-against-solid-cancers-and-secures-major-Austrian-grant-funding.html
https://www.globenewswire.com/news-release/2023/06/19/2690320/0/en/invIOs-presents-exciting-preclinical-data-showing-that-immune-activating-small-molecule-INV501-induces-strong-cytotoxic-activity-against-solid-tumors.html
https://www.globenewswire.com/news-release/2022/12/14/2573601/0/en/invIOs-to-present-at-Biotech-Showcase.html
https://www.globenewswire.com/news-release/2022/11/10/2553428/0/en/invIOs-presents-positive-patient-data-from-ongoing-Phase-1b-trial-of-APN401-cell-therapy-in-advanced-solid-tumors-at-SITC-2022.html
https://www.globenewswire.com/news-release/2022/10/18/2535992/0/en/invIOs-to-present-data-from-clinical-stage-Cbl-b-program-at-SITC-2022.html
https://www.globenewswire.com/news-release/2022/10/11/2531440/0/en/invIOs-to-present-at-upcoming-industry-and-investor-conferences.html
Market Place
Share 
